IMTX
NASDAQ · Biotechnology
Immatics Nv
$8.62
-0.20 (-2.27%)
Open$8.76
Previous Close$8.82
Day High$8.86
Day Low$8.48
52W High$12.41
52W Low$5.92
Volume—
Avg Volume521.7K
Market Cap1.32B
P/E Ratio—
EPS$-1.59
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+796.2% upside
Current
$8.62
$8.62
Target
$77.25
$77.25
$52.47
$77.25 avg
$103.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 57.72M | 88.30M | 330.72M |
| Net Income | -234,928,223 | -323,444,088 | -35,950,365 |
| Profit Margin | -407.0% | -386.7% | -10.9% |
| EBITDA | -206,703,476 | -300,395,138 | -62,958,224 |
| Free Cash Flow | — | — | -53,039,983 |
| Rev Growth | -34.6% | -34.6% | -2.7% |
| Debt/Equity | 0.03 | 0.03 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |